Celcuity rises after upsized convertible bond, stock sale
Brief: Celcuity Inc. Announces Pricing Of Concurrent Public Offerings
U.S. STOCKS ON THE MOVE-CenterPoint Energy, Duke Energy, CyberArk Software
U.S. STOCKS ON THE MOVE-Boeing, Corning, Chart Industries
Celcuity dips premarket after convertible bond, stock offerings unveiled
U.S. RESEARCH ROUNDUP-Cadence Design Systems, Coinbase Global, Kinsale Capital Group
U.S. STOCKS ON THE MOVE-CervoMed, Talen Energy, PACCAR
U.S. STOCKS ON THE MOVE-CervoMed, Talen Energy, PACCAR
Celcuity hits record high on breast cancer drug trial data
Celcuity's triple drug combo tops AstraZeneca's treatment in breast cancer trial (updated)
U.S. STOCKS ON THE MOVE-PagerDuty, CervoMed, Talen Energy
U.S. STOCKS ON THE MOVE-Tesla, Nike, Pfizer
Celcuity's triple cancer drug combo tops AstraZeneca's in cutting progression in study
Celcuity soars on breast cancer drug trial data
Brief: Celcuity Reports PFS Improvement in PIK3CA WT Cohort of Phase 3 VIKTORIA-1 Breast Cancer Trial
Brief: Celcuity Announces Positive Topline Results From PIK3CA Wild-Type Cohort Of Phase 3 VIKTORIA-1 Clinical Trial
Brief: Celcuity Announces First Patient Dosed In Phase 3 Viktoria-2 Clinical Trial Of Gedatolisib
Brief: Celcuity Reports Clinical Data From Two Early Phase Studies Of Gedatolisib
Celcuity Inc reports results for the quarter ended March 31 - Earnings Summary